The treatment of hepatitis C has become safer, better tolerated and more effective owing to
the availability of direct-acting antivirals for nearly all patients; this guideline advocates …

Chronic hepatitis C remains a significant medical and economic burden in Canada, affecting
nearly 1% of the population. Since the last Canadian consensus conference on the …

Abstract Chronic Hepatitis C virus (HCV) infection carries a significant clinical burden in the
United States, affecting more than 4.6 million Americans. Untreated chronic HCV infection …

With an estimated prevalence of about 170 million people worldwide, chronic hepatitis C is
an important cause of chronic liver disease associated with a substantial risk of cirrhosis and …

Background: Chronic hepatitis C virus (HCV) infection can lead to liver cirrhosis and its
complications. Viral eradication is essential to prevent disease progression and reduces …

Recent data have clearly shown that a sustained virologic response can be achieved in
different HCV infected patient populations with various interferon-free treatment regimens …

Hepatitis C virus (HCV) infection results in a chronic carrier state in 80% of individuals
infected with the virus and presently affects over 170 million people worldwide …

Chronic hepatitis C remains a significant medical and economic burden in Canada, affecting
nearly 1% of the population. Since the last consensus conference on the management of …

Current treatment for chronic hepatitis C (CHC) is highly efficacious, well-tolerated, and of
short duration for the majority of patients. Despite the dramatic advances in therapy, there …

Importance Hepatitis C virus (HCV) infects more than 185 million individuals worldwide.
Twenty percent of patients chronically infected with HCV progress to cirrhosis. New, simpler …